Javelin Pharmaceuticals, Inc. (AMEX: JAV)

Javelin Pharmaceuticals, Inc. (AMEX: JAV), a specialty pharmaceutical company, is focused on applying its novel proprietary technologies to develop new drugs and improve existing drugs that target unmet as well as underserved medical needs in the pain management market. Compared to existing treatments, Javelin’s product candidates, which include Dyloject™, Rylomine™ and PMI-150, provide better pain relief with fewer adverse side effects. For further information, visit the Company’s web site at www.javelinpharma.com.